查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829882

2025年全球呼吸診斷設備市場報告

Respiratory Devices And Equipment (Diagnostic) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，呼吸診斷設備市場呈現強勁成長勢頭，市場規模從2024年的78.1億美元成長至2025年的83.6億美元，複合年成長率為7.0%。預測期內的成長歸因於慢性呼吸系統疾病、人口老化、吸菸、環境因素以及技術進步。

預計未來幾年呼吸診斷市場將強勁成長，到2029年將達到121.3億美元，複合年成長率為9.8%。預測期內的成長將受到呼吸道感染疾病、遠端醫療和遠端監控、個人化醫療以及人工智慧和機器學習的推動。預測期內的主要趨勢包括肺功能測試 (PFT)、家庭呼吸監測、遠端醫療整合以及戒菸輔助工具。

呼吸診斷設備和儀器用於診斷氣喘、囊腫纖維化和慢性阻塞性肺病等呼吸系統疾病。這些設備可測量肺功能和血氧水平，幫助醫療保健提供者評估和管理呼吸系統健康狀況。

呼吸診斷設備市場的關鍵產品包括儀器和設備，以及檢測試劑和試劑。這些呼吸器材與設備對於診斷各種呼吸系統疾病至關重要。診斷測試種類繁多，包括傳統診斷測試、機械測試、影像檢查和分子診斷測試，所有這些測試都用於診斷慢性阻塞性肺病(COPD)、肺癌、氣喘、結核病和其他呼吸系統疾病。這些診斷工具用於各種醫療保健場所，例如醫院、臨床實驗室、醫生辦公室、參考實驗室和其他最終使用者設施。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供呼吸設備及器械（診斷）市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的呼吸設備及器械（診斷）細分市場、市場趨勢和機遇，以及您在呼吸設備及器械（診斷）行業取得成功所需的數據。本呼吸設備及器械（診斷）市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長9.8%，較先前預測略有下降0.4%。這一下降主要源自於美國與其他國家之間關稅的影響。該影響可能透過對主要來自法國和加拿大的肺量計流量感測器和氣體分析儀組件徵收關稅直接影響美國，並將增加肺功能測試的成本。此外，互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響也將更廣泛地反映出來。

各種呼吸系統疾病的盛行率不斷上升，增加了對用於診斷和治療的診斷儀器和設備的需求，從而促進了全球呼吸設備和器械市場的成長。慢性阻塞性肺病(COPD) 等疾病在老年人中特別常見。 COPD 是阻塞型肺疾。例如，2024 年 7 月，澳洲政府機構澳洲健康與福利研究所報告稱，2022 年死於 COPD 的人數將達到 7,691 人，即每 100,000 人口中有 29.6 人死亡，佔所有死亡人數的 4.0%。因此，病例數的增加推動了對診斷儀器和設備的需求，刺激了呼吸設備和器械（診斷）市場的擴張。

預計人口老化將成為呼吸設備市場成長的促進因素，尤其是在診斷領域。老化是指社會和人口中老年人口比例不斷增加的人口結構變化。呼吸診斷設備和儀器在監測和管理老年人口的呼吸健康方面發揮關鍵作用，有助於早期發現和介入慢性阻塞性肺病 (COPD) 和睡眠呼吸中止症等疾病。截至2022年7月，聯合國經濟社會事務部預測，全球65歲及以上人口的比例將從2022年的10%上升到2050年的16%。因此，不斷成長的老齡化人口將成為呼吸診斷設備和儀器市場擴張的催化劑。

呼吸設備和器材市場的公司正擴大投資於可攜式和無線診斷工具。這一趨勢的驅動力在於它們的易用性、成本效益、先進的功能以及與居家醫療環境的兼容性。與傳統設備相比，配備創新技術的攜帶式呼吸設備正在引入市場，這些設備可以即時診斷呼吸頻率和脈搏率等生命徵象。例如，美國政府機構國家生物技術資訊中心在2024年5月強調，這些攜帶式非侵入式設備可立即提供結果，這對於患有慢性阻塞性肺病（COPD）和氣喘等慢性呼吸系統疾病的患者至關重要。現場診斷可改善患者預後並提高醫療保健系統的效率。

呼吸診斷市場的主要企業正致力於開發先進的診斷技術，例如自動核酸純化儀器和Applied Biosystems MagMAX Dx病毒/病原體核酸分離試劑盒，以提高病毒檢測的準確性和速度。這些儀器和套件能夠快速可靠地提取病毒遺傳物質，以便進行準確的診斷測試。例如，2023年12月，美國生技公司賽默飛世爾科技宣布推出呼吸診斷測試的樣品製備解決方案。賽默飛世爾科技的KingFisher Apex Dx可自動純化多達24或96個DNA、RNA、蛋白質和細胞樣本，確保呼吸測試的高品質結果。與Applied Biosystems MagMAX Dx病毒/病原體核酸分離試劑盒結合使用時，它可提供全面的體外診斷解決方案。該系統配備先進的數據管理和網路安全安全功能，支援從樣品製備到即時PCR分析的順暢工作流程，使其適用於研究和診斷目的。

2022年1月，美國醫療設備製造商ICU Medical Inc.以23.5億美元收購了史密斯醫療公司。此次策略性收購涵蓋了史密斯醫療的注射器、門診輸液設備、血管通路解決方案以及重症監護產品。此次收購預計將增強ICU Medical的輸液治療產品系列，使其能夠服務新興的臨床護理市場。史密斯醫療公司總部位於美國，致力於開發、製造和銷售呼吸診斷設備等醫療產品。

呼吸診斷市場的主要參與者包括 ResMed Inc.、Medtronic plc、Masimo Corporation、Fisher & Paykel Healthcare Limited、Koninklijke Philips NV、Smiths Medical、GE Healthcare、Chart Industries Inc.、Philips Healthcare、Becton Dickinson and Company (BD)、Abbott Laboratories、ThePat 至 Fisher Scientic Inc. Fisher. Fisher Scicire、Yia Co. KGaA、Getinge AB、Drager Medical GmbH、bioMerieux、Bio-Rad Laboratories Inc.、Cosmed Srl、Seegene Inc.、SDI Diagnostics、GlaxoSmithKline plc、Hillrom、Hamilton Medical AG、Medline Industries Inc、3M Company、Air Liquideline plc、Hillrom、Hamilton Medical AG、Medline Industries Inc、 工業 Corporation 和 O2 Concepts LLC。

2024年，亞太地區是呼吸器材及器材（診斷）市場最大的地區。北美是呼吸器材及器材（診斷）市場的第二大地區。呼吸設備及器材（診斷）市場報告涵蓋亞太地區、西歐、東歐、北美、南美、中東和非洲。

呼吸設備和裝置（診斷）市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、西班牙和加拿大

呼吸診斷設備市場包括肺計量計、睡眠多項生理檢查、峰值流量計以及用於診斷呼吸系統疾病的監測設備（例如脈動式血氧監測儀系統、二氧化碳分析儀和氣體分析儀）的銷售。該市場的商品價值為出廠價，即商品製造商或生產者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場的商品價值還包括商品生產者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球呼吸設備與器材（診斷）：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球呼吸診斷器材與設備市場：成長率分析
  • 全球呼吸診斷器材與設備市場表現：規模與成長，2019-2024
  • 全球呼吸診斷器材與設備市場預測：規模和成長，2024-2029年，2034年
  • 全球呼吸器材與設備（診斷）：總目標市場（TAM）

第6章 市場細分

  • 全球呼吸診斷設備市場：依產品、績效及預測，2019-2024年、2024-2029年、2034年
  • 設備和裝置
  • 檢測方法和試劑
  • 全球呼吸診斷設備市場（按測試類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 傳統診斷測試
  • 機械檢查
  • 影像檢查
  • 分子診斷測試
  • 全球呼吸診斷設備市場（按疾病類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 慢性阻塞性肺病
  • 肺癌
  • 氣喘
  • 結核
  • 其他疾病
  • 全球呼吸診斷設備市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院或臨床實驗室
  • 醫生診所
  • 參考實驗室
  • 其他最終用戶
  • 全球呼吸診斷器材與設備市場：按器材與設備（類型）、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 肺計量計
  • 脈動式血氧監測儀系統
  • 峰值流量計
  • 二氧化碳測量儀
  • 呼吸壓力監測器
  • 可攜式人工呼吸器
  • 全球呼吸診斷器材與設備市場：按分析和試劑類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 診斷試劑套件
  • 呼吸道感染疾病試劑
  • 血氣分析試劑
  • 呼吸道病原體 PCR 檢測

第7章 區域和國家分析

  • 全球呼吸診斷設備市場：按地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球呼吸診斷設備市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 呼吸器材與設備（診斷）市場：競爭格局
  • 呼吸器材與設備（診斷）市場：公司簡介
    • ResMed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Masimo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Fisher & Paykel Healthcare Limited Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Smiths Medical
  • GE Healthcare
  • Chart Industries Inc.
  • Philips Healthcare
  • Becton Dickinson and Company（BD）
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Teleflex Incorporated
  • Invacare Corporation
  • Vyaire Medical Inc.
  • Dragerwerk AG & Co. KGaA
  • Getinge AB
  • Drager Medical GmbH
  • bioMerieux
  • Bio-Rad Laboratories Inc-Bio-Rad Laboratories Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年呼吸診斷設備：提供新機會的國家
  • 2029年呼吸診斷設備：細分市場將帶來新機會
  • 2029年呼吸診斷設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r32754u

Respiratory diagnostic devices and equipment are used to diagnose respiratory conditions like asthma, cystic fibrosis, and chronic obstructive pulmonary disease. These devices help measure lung function and oxygen levels, assisting healthcare providers in assessing and managing respiratory health.

The primary products within the respiratory devices and equipment (diagnostic) market encompass instruments and devices, as well as assays and reagents. These respiratory instruments and devices are critical for the diagnosis of various respiratory disorders. Diagnostic tests are available in various types, including traditional diagnostic tests, mechanical tests, imaging tests, and molecular diagnostic tests, all of which are employed in diagnosing conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, asthma, tuberculosis, and other respiratory diseases. These diagnostic tools are used in a variety of healthcare settings, including hospital and clinical laboratories, physician offices, reference laboratories, and other end-user facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The respiratory devices and equipment (diagnostic) market research report is one of a series of new reports from The Business Research Company that provides respiratory devices and equipment (diagnostic) market statistics, including respiratory devices and equipment (diagnostic) industry global market size, regional shares, competitors with a respiratory devices and equipment (diagnostic) market share, detailed respiratory devices and equipment (diagnostic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (diagnostic) industry. This respiratory devices and equipment (diagnostic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory devices and equipment (diagnostic) market size has grown strongly in recent years. It will grow from $7.81 billion in 2024 to $8.36 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to chronic respiratory diseases, aging population, smoking and environmental factors, technological advancements.

The respiratory devices and equipment (diagnostic) market size is expected to see strong growth in the next few years. It will grow to $12.13 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to respiratory infections, telemedicine and remote monitoring, personalized medicine, ai and machine learning. Major trends in the forecast period include pulmonary function testing (pft), home respiratory monitoring, telemedicine integration, smoking cessation aids.

The forecast of 9.8% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on spirometry flow sensors and gas analyzer components, primarily sourced from France and Canada, increasing costs for lung function testing.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of various respiratory diseases has contributed to the growth of the global respiratory devices and equipment market by increasing the demand for diagnostic devices and equipment for diagnosis and treatment. Conditions such as chronic obstructive pulmonary disease (COPD) are particularly common among the elderly. COPD is an obstructive lung disease that causes long-term breathing difficulties. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2022, COPD was responsible for 7,691 deaths, or 29.6 per 100,000 people, accounting for 4.0% of all fatalities. As a result, the growing number of such cases has driven the demand for diagnostic devices and equipment, thus fueling the expansion of the respiratory devices and equipment (diagnostic) market.

The aging population is anticipated to be a key driver of growth in the respiratory devices and equipment market, especially in the diagnostic segment. An aging population refers to the demographic shift characterized by a rising proportion of elderly individuals within a society or population. Respiratory diagnostic devices and equipment play a pivotal role in monitoring and managing respiratory health for the aging population, aiding in early detection and intervention for conditions like COPD and sleep apnea. As of July 2022, the United Nations Department of Economic and Social Affairs has projected that the proportion of the world's population aged 65 and older is expected to increase from 10% in 2022 to 16% by 2050. Consequently, the growing aging population acts as a catalyst for the expansion of the respiratory devices and equipment (diagnostic) market.

Companies in the respiratory devices and equipment market are increasingly investing in portable and wireless diagnostic tools. This trend is driven by the ease of use, cost-effectiveness, advanced features, and their suitability for home care settings. Innovative, technology-enabled portable respiratory devices are being introduced to the market, offering immediate diagnosis of vital signs such as respiratory and pulse rates, in contrast to traditional devices. For example, in May 2024, the National Center for Biotechnology Information, a U.S.-based government agency, highlighted that this portable, noninvasive device provides immediate results, making it crucial for patients with chronic respiratory conditions like COPD and asthma. By offering on-site diagnostics, it improves patient outcomes and enhances the efficiency of healthcare systems.

Leading companies in the respiratory devices and equipment (diagnostic) market are focusing on developing advanced diagnostic technologies, such as automated nucleic acid purification instruments and the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, to improve the accuracy and speed of viral detection. These instruments and kits enable the quick and reliable extraction of viral genetic material for precise diagnostic testing. For instance, in December 2023, Thermo Fisher Scientific Inc., a U.S.-based biotechnology company, introduced Sample Preparation Solutions for Respiratory Diagnostic Testing. The Thermo Scientific KingFisher Apex Dx automates the purification of up to 24 or 96 samples of DNA, RNA, proteins, or cells, ensuring high-quality results for respiratory tests. It integrates with the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, providing a comprehensive solution for in vitro diagnostics. With advanced data management and cybersecurity features, this system supports smooth workflows from sample preparation to real-time PCR analysis, making it suitable for both research and diagnostic purposes.

In January 2022, ICU Medical Inc., a U.S.-based medical device company, completed the acquisition of Smiths Medical for $2.35 billion. This strategic acquisition included Smiths Medical's syringe and ambulatory infusion devices, vascular access solutions, and vital care products. It was expected to strengthen ICU Medical's infusion therapy product portfolio and extend its offerings into emerging clinical care markets. Smiths Medical is a U.S.-based firm that develops, manufactures, and sells medical products, including diagnostic respiratory devices and equipment.

Major companies operating in the respiratory devices and equipment (diagnostic) market include ResMed Inc., Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Chart Industries Inc., Philips Healthcare, Becton Dickinson and Company (BD), Abbott Laboratories, Thermo Fisher Scientific Inc., Teleflex Incorporated, Invacare Corporation, Vyaire Medical Inc., Dragerwerk AG & Co. KGaA, Getinge AB, Drager Medical GmbH, bioMerieux, Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc., Cosmed S.r.l., Seegene Inc., SDI Diagnostics, GlaxoSmithKline plc, Hillrom, Hamilton Medical AG, Medline Industries Inc., 3M Company, Air Liquide, Allied Healthcare Products Inc., Armstrong Medical, Bio-Med Devices Inc., Breas Medical AB, CAIRE Inc., DeVilbiss Healthcare, Nihon Kohden Corporation, O2 Concepts LLC

Asia-Pacific was the largest region in the respiratory devices and equipment (diagnostic) market in 2024. North America was the second largest region in the respiratory devices and equipment (diagnostic) market. The regions covered in the respiratory devices and equipment (diagnostic) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the respiratory devices and equipment (diagnostic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The respiratory devices and equipment (diagnostic) market consist of sales of spirometer, polysomnographs, and peak flow meters and monitoring devices are pulse oximeters, capnography, and gas analyzers that are used for diagnosis of respiratory diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Devices And Equipment (Diagnostic) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory devices and equipment (diagnostic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory devices and equipment (diagnostic) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory devices and equipment (diagnostic) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments And Devices; Assays And Reagents
  • 2) By Test Type: Traditional Diagnostic Tests; Mechanical Tests; Imaging Tests; Molecular Diagnostic Tests
  • 3) By Disease Type: Chronic Obstructive Pulmonary Disease; Lung Cancer; Asthma; Tuberculosis; Other Diseases
  • 4) By End User: Hospital/Clinical Laboratories; Physician Offices; Reference Laboratories; Other End Users
  • Subsegments:
  • 1) By Instruments And Devices: Spirometers; Pulse Oximeters; Peak Flow Meters; Capnographs; Respiratory Pressure Monitors; Portable Ventilators
  • 2) By Assays And Reagents: Diagnostic Kits; Reagents For Respiratory Infections; Blood Gas Analysis Reagents; PCR Assays For Respiratory Pathogens
  • Companies Mentioned: ResMed Inc.; Medtronic plc; Masimo Corporation; Fisher & Paykel Healthcare Limited; Koninklijke Philips N.V.; Smiths Medical; GE Healthcare; Chart Industries Inc.; Philips Healthcare; Becton Dickinson and Company (BD); Abbott Laboratories; Thermo Fisher Scientific Inc.; Teleflex Incorporated; Invacare Corporation; Vyaire Medical Inc.; Dragerwerk AG & Co. KGaA; Getinge AB; Drager Medical GmbH; bioMerieux; Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc.; Cosmed S.r.l.; Seegene Inc.; SDI Diagnostics; GlaxoSmithKline plc; Hillrom; Hamilton Medical AG; Medline Industries Inc.; 3M Company; Air Liquide; Allied Healthcare Products Inc.; Armstrong Medical; Bio-Med Devices Inc.; Breas Medical AB; CAIRE Inc.; DeVilbiss Healthcare; Nihon Kohden Corporation; O2 Concepts LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Devices And Equipment (Diagnostic) Market Characteristics

3. Respiratory Devices And Equipment (Diagnostic) Market Trends And Strategies

4. Respiratory Devices And Equipment (Diagnostic) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Respiratory Devices And Equipment (Diagnostic) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Respiratory Devices And Equipment (Diagnostic) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Respiratory Devices And Equipment (Diagnostic) Market Growth Rate Analysis
  • 5.4. Global Respiratory Devices And Equipment (Diagnostic) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Respiratory Devices And Equipment (Diagnostic) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Respiratory Devices And Equipment (Diagnostic) Total Addressable Market (TAM)

6. Respiratory Devices And Equipment (Diagnostic) Market Segmentation

  • 6.1. Global Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments And Devices
  • Assays And Reagents
  • 6.2. Global Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Diagnostic Tests
  • Mechanical Tests
  • Imaging Tests
  • Molecular Diagnostic Tests
  • 6.3. Global Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chronic Obstructive Pulmonary Disease
  • Lung Cancer
  • Asthma
  • Tuberculosis
  • Other Diseases
  • 6.4. Global Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Or Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Other End Users
  • 6.5. Global Respiratory Devices And Equipment (Diagnostic) Market, Sub-Segmentation Of Instruments And Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spirometers
  • Pulse Oximeters
  • Peak Flow Meters
  • Capnographs
  • Respiratory Pressure Monitors
  • Portable Ventilators
  • 6.6. Global Respiratory Devices And Equipment (Diagnostic) Market, Sub-Segmentation Of Assays And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Kits
  • Reagents For Respiratory Infections
  • Blood Gas Analysis Reagents
  • PCR Assays For Respiratory Pathogens

7. Respiratory Devices And Equipment (Diagnostic) Market Regional And Country Analysis

  • 7.1. Global Respiratory Devices And Equipment (Diagnostic) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Respiratory Devices And Equipment (Diagnostic) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Devices And Equipment (Diagnostic) Market

  • 8.1. Asia-Pacific Respiratory Devices And Equipment (Diagnostic) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Devices And Equipment (Diagnostic) Market

  • 9.1. China Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 9.2. China Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Devices And Equipment (Diagnostic) Market

  • 10.1. India Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Devices And Equipment (Diagnostic) Market

  • 11.1. Japan Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 11.2. Japan Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Devices And Equipment (Diagnostic) Market

  • 12.1. Australia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Devices And Equipment (Diagnostic) Market

  • 13.1. Indonesia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Devices And Equipment (Diagnostic) Market

  • 14.1. South Korea Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 14.2. South Korea Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Devices And Equipment (Diagnostic) Market

  • 15.1. Western Europe Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 15.2. Western Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Devices And Equipment (Diagnostic) Market

  • 16.1. UK Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Devices And Equipment (Diagnostic) Market

  • 17.1. Germany Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Devices And Equipment (Diagnostic) Market

  • 18.1. France Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Devices And Equipment (Diagnostic) Market

  • 19.1. Italy Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Devices And Equipment (Diagnostic) Market

  • 20.1. Spain Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Devices And Equipment (Diagnostic) Market

  • 21.1. Eastern Europe Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 21.2. Eastern Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Devices And Equipment (Diagnostic) Market

  • 22.1. Russia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Devices And Equipment (Diagnostic) Market

  • 23.1. North America Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 23.2. North America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Devices And Equipment (Diagnostic) Market

  • 24.1. USA Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 24.2. USA Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Devices And Equipment (Diagnostic) Market

  • 25.1. Canada Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 25.2. Canada Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Devices And Equipment (Diagnostic) Market

  • 26.1. South America Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 26.2. South America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Devices And Equipment (Diagnostic) Market

  • 27.1. Brazil Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Devices And Equipment (Diagnostic) Market

  • 28.1. Middle East Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 28.2. Middle East Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Devices And Equipment (Diagnostic) Market

  • 29.1. Africa Respiratory Devices And Equipment (Diagnostic) Market Overview
  • 29.2. Africa Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Respiratory Devices And Equipment (Diagnostic) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Devices And Equipment (Diagnostic) Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Devices And Equipment (Diagnostic) Market Competitive Landscape
  • 30.2. Respiratory Devices And Equipment (Diagnostic) Market Company Profiles
    • 30.2.1. ResMed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Masimo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Fisher & Paykel Healthcare Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Devices And Equipment (Diagnostic) Market Other Major And Innovative Companies

  • 31.1. Smiths Medical
  • 31.2. GE Healthcare
  • 31.3. Chart Industries Inc.
  • 31.4. Philips Healthcare
  • 31.5. Becton Dickinson and Company (BD)
  • 31.6. Abbott Laboratories
  • 31.7. Thermo Fisher Scientific Inc.
  • 31.8. Teleflex Incorporated
  • 31.9. Invacare Corporation
  • 31.10. Vyaire Medical Inc.
  • 31.11. Dragerwerk AG & Co. KGaA
  • 31.12. Getinge AB
  • 31.13. Drager Medical GmbH
  • 31.14. bioMerieux
  • 31.15. Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc.

32. Global Respiratory Devices And Equipment (Diagnostic) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Devices And Equipment (Diagnostic) Market

34. Recent Developments In The Respiratory Devices And Equipment (Diagnostic) Market

35. Respiratory Devices And Equipment (Diagnostic) Market High Potential Countries, Segments and Strategies

  • 35.1 Respiratory Devices And Equipment (Diagnostic) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Respiratory Devices And Equipment (Diagnostic) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Respiratory Devices And Equipment (Diagnostic) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer